Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Miyajima

Showing results (11-20 of 248) with videos related to

Pageof 25
Sort By:
Clinical and Experimental Nephrology|January 23, 2008
Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case reportTakeo Kosaka, Shuji Mikami, Akira Miyajima, et al.
Internal Medicine (Tokyo, Japan)|May 18, 2011
Renal cell carcinoma accompanied by left-sided IVCTakahiro Maeda, Akira Miyajima, Eiji Kikuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 3, 2015
Renin-angiotensin system blockade: Its contribution and controversyAkira Miyajima, Takeo Kosaka, Eiji Kikuchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[A Case of Non-Treated Prostate Cancer with Disseminated Intravascular Coagulopathy]Tatsuya Umemoto, Masatoshi Tokunaga, Hideshi Miyakita, et al.
The Journal of Urology|January 18, 2011
Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumorTakahiro Maeda, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
Journal of Endourology|September 27, 2006
Endocytoscopy: novel endoscopic imaging technology for in-situ observation of bladder cancer cellsTakashi Ohigashi, Norihide Kozakai, Ryuichi Mizuno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Japanese Journal of Clinical Oncology|May 8, 2012
The benefit of laparoscopic partial nephrectomy in high body mass index patientsGou Kaneko, Akira Miyajima, Eiji Kikuchi, et al.
The Prostate|February 16, 2011
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancerTakeo Kosaka, Akira Miyajima, Suguru Shirotake, et al.
Springerplus|December 21, 2016
Influence of physician years on urological journal publication productivity among Japanese urologistsNaoya Niwa, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
Pageof 25

Showing results (11-20 of 248) with videos related to

Sort By:
Pageof 25
Clinical and Experimental Nephrology|January 23, 2008
Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case reportTakeo Kosaka, Shuji Mikami, Akira Miyajima, et al.
Internal Medicine (Tokyo, Japan)|May 18, 2011
Renal cell carcinoma accompanied by left-sided IVCTakahiro Maeda, Akira Miyajima, Eiji Kikuchi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 3, 2015
Renin-angiotensin system blockade: Its contribution and controversyAkira Miyajima, Takeo Kosaka, Eiji Kikuchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[A Case of Non-Treated Prostate Cancer with Disseminated Intravascular Coagulopathy]Tatsuya Umemoto, Masatoshi Tokunaga, Hideshi Miyakita, et al.
The Journal of Urology|January 18, 2011
Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumorTakahiro Maeda, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
Journal of Endourology|September 27, 2006
Endocytoscopy: novel endoscopic imaging technology for in-situ observation of bladder cancer cellsTakashi Ohigashi, Norihide Kozakai, Ryuichi Mizuno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancerMichio Kosugi, Akira Miyajima, Eiji Kikuchi, et al.
Japanese Journal of Clinical Oncology|May 8, 2012
The benefit of laparoscopic partial nephrectomy in high body mass index patientsGou Kaneko, Akira Miyajima, Eiji Kikuchi, et al.
The Prostate|February 16, 2011
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancerTakeo Kosaka, Akira Miyajima, Suguru Shirotake, et al.
Springerplus|December 21, 2016
Influence of physician years on urological journal publication productivity among Japanese urologistsNaoya Niwa, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
Pageof 25